WEP CLINICAL HAS PARTNERED WITH KYOWA KIRIN TO LAUNCH CRYSViTA® (burosumab) POST-APPROVAL NAMED PATIENT PROGRAM IN ASIA PACIFIC
WEP Clinical LTD (WEP), a specialist services company that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available, has partnered with Japan-based [...]